Neuropharmacogenetics and behavioral genetics

Behav Genet. 1982 Feb;12(1):111-21. doi: 10.1007/BF01065744.

Abstract

Genetic studies of neurotransmitter processes to date differ from most behavioral genetic studies in that the former have rarely considered individual variability, have tended to look only for single-gene effects, and generally have overlooked or ignored environmental influences. After examining these differences, we suggest that a rapprochement between the two fields will yield synergistic benefits in studies of the genetics of neuropharmacological processes as they affect behavior.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blood Platelets / enzymology
  • Dopamine beta-Hydroxylase / genetics
  • Genetic Variation
  • Genetics, Behavioral
  • Humans
  • Mental Disorders / genetics*
  • Mental Disorders / psychology
  • Molecular Biology
  • Monoamine Oxidase / genetics
  • Neurotransmitter Agents / metabolism*
  • Phenotype
  • Phenylethanolamine N-Methyltransferase / genetics
  • Research
  • Social Environment
  • Tyrosine 3-Monooxygenase / genetics

Substances

  • Neurotransmitter Agents
  • Tyrosine 3-Monooxygenase
  • Dopamine beta-Hydroxylase
  • Monoamine Oxidase
  • Phenylethanolamine N-Methyltransferase